Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mudaliar
R R Henry

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
Journal of Diabetes and Its Complications|March 2, 2002
Role of glycogen synthase kinase-3 in skeletal muscle insulin resistance in Type 2 diabetesT P Ciaraldi, S E Nikoulina, R R Henry
Diabetes, Obesity & Metabolism|October 11, 2016
Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetesS Mudaliar, R R Henry, T P Ciaraldi, et al.
Diabetes|February 1, 1990
Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDMR R Henry, B Gumbiner, T Flynn, et al.
Diabetes|January 1, 1990
Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjectsA W Thorburn, B Gumbiner, G Brechtel, et al.
The American Journal of Physiology|July 1, 1991
Dose-response characteristics of impaired glucose oxidation in non-insulin-dependent diabetes mellitusR R Henry, A W Thorburn, P Beerdsen, et al.
Diabetes|August 1, 1995
Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell culturesR R Henry, L Abrams, S Nikoulina, et al.
Metabolism: Clinical and Experimental|April 1, 1991
Substrate oxidation errors during combined indirect calorimetry-hyperinsulinemic glucose clamp studiesA W Thorburn, B Gumbiner, T Flynn, et al.
Journal of the American Dietetic Association|November 1, 1979
Mass balance: a quantitative guide to clinical nutritional therapy. II. The dialyzed patientJ A Sargent, F A Gotch, R R Henry, et al.
Diabetes|April 2, 1999
Inhibition of LDL oxidation in vitro but not ex vivo by troglitazoneR S Crawford, S R Mudaliar, R R Henry, et al.
The Journal of Clinical Investigation|October 1, 1988
Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight lossG R Freidenberg, D Reichart, J M Olefsky, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
Journal of Diabetes and Its Complications|March 2, 2002
Role of glycogen synthase kinase-3 in skeletal muscle insulin resistance in Type 2 diabetesT P Ciaraldi, S E Nikoulina, R R Henry
Diabetes, Obesity & Metabolism|October 11, 2016
Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetesS Mudaliar, R R Henry, T P Ciaraldi, et al.
Diabetes|February 1, 1990
Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDMR R Henry, B Gumbiner, T Flynn, et al.
Diabetes|January 1, 1990
Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjectsA W Thorburn, B Gumbiner, G Brechtel, et al.
The American Journal of Physiology|July 1, 1991
Dose-response characteristics of impaired glucose oxidation in non-insulin-dependent diabetes mellitusR R Henry, A W Thorburn, P Beerdsen, et al.
Diabetes|August 1, 1995
Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell culturesR R Henry, L Abrams, S Nikoulina, et al.
Metabolism: Clinical and Experimental|April 1, 1991
Substrate oxidation errors during combined indirect calorimetry-hyperinsulinemic glucose clamp studiesA W Thorburn, B Gumbiner, T Flynn, et al.
Journal of the American Dietetic Association|November 1, 1979
Mass balance: a quantitative guide to clinical nutritional therapy. II. The dialyzed patientJ A Sargent, F A Gotch, R R Henry, et al.
Diabetes|April 2, 1999
Inhibition of LDL oxidation in vitro but not ex vivo by troglitazoneR S Crawford, S R Mudaliar, R R Henry, et al.
The Journal of Clinical Investigation|October 1, 1988
Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight lossG R Freidenberg, D Reichart, J M Olefsky, et al.
Pageof 14